Tisagenlecleucel for annual requirement in therapy programs B.12.FM and B.65
Delivery of Tisagenlecleucel: Annual requirement for therapy programs B.12.FM "Treatment of patients with B-cell lymphomas" and B.65 "Treatment of patients with acute lymphoblastic leukemia" for UCK; further items as per the tender documents.
CONTRACTING AUTHORITY
Name
Uniwersyteckie Centrum Kliniczne
City
Gdańsk
Country
PL
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
14 days remaining(LOT-0001)
Published